Meng-yao Wang
Guangzhou, 510095, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Induction chemotherapy with nedaplatin, docetaxel and 5-fluorouracil followed by concurrent nedaplatin and radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A single arm, open label, phase II clinical trial.
Journal: Translational oncology
Published: September 04, 2024
Inactivation of TACC2 epigenetically represses CDKN1A and confers sensitivity to CDK inhibitors.
Journal: Med (New York, N.Y.)
Published: February 22, 2024
Subphrenic Lymph Node Metastasis Predicts Poorer Prognosis for Nasopharyngeal Carcinoma Patients With Metachronous Metastasis.
Journal: Frontiers in oncology
Published: June 16, 2021
Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
Journal: Annals of translational medicine
Published: June 04, 2021
FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration.
Journal: Frontiers in oncology
Published: January 21, 2021
PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma.
Journal: Oncogenesis
Published: June 02, 2020
Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence.
Journal: Cell death & disease
Published: December 01, 2018
Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways.
Journal: Cancer biology & therapy
Published: August 12, 2017
The developmental transcription factor IRF6 attenuates ABCG2 gene expression and distinctively reverses stemness phenotype in nasopharyngeal carcinoma.
Journal: Cancer letters
Published: June 08, 2017
Last Updated: 09/26/2026